Drug Profile
UK 78624
Alternative Names: N 7871824Latest Information Update: 27 Jul 2000
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anthelmintics; Antibacterials; Macrolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Helminthiasis
Most Recent Events
- 27 Jul 2000 Profile reviewed but no significant changes made
- 20 Jul 1998 No-Development-Reported for Helminthiasis in Japan (Unknown route)
- 20 Jul 1998 No-Development-Reported for Helminthiasis in United Kingdom (Unknown route)